Business Description
Garofalo Health Care SpA
ISIN : IT0005345233
Share Class Description:
CHIX:GHCm: Ordinary SharesTotal Employee Number:
2,714Compare
Compare
Traded in other countries / regions
GHC.ItalyGHC.GermanyGHCm.UK IPO Date
2019-03-19Description
Garofalo Health Care SpA is an Italian accredited private healthcare provider offering a comprehensive range of services across various areas of healthcare through diversified specialties, supported by the use of technologies and qualified personnel. The Group mainly operates in regions of northern and central Italy, which have been selected based on their attractiveness in terms of per capita healthcare spending, above-average per capita income, and well-developed internal transport infrastructure.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.68 | |||||
Debt-to-EBITDA | 3.31 | |||||
Interest Coverage | 5.04 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.28 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15 | |||||
3-Year EBITDA Growth Rate | 13.5 | |||||
3-Year EPS without NRI Growth Rate | 5.3 | |||||
3-Year FCF Growth Rate | -18.6 | |||||
3-Year Book Growth Rate | 6.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 6.53 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.96 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.15 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 30.72 | |||||
Days Sales Outstanding | 96.93 | |||||
Days Payable | 424.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.25 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 1.36 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 84.6 | |||||
Operating Margin % | 11.04 | |||||
Net Margin % | 4.44 | |||||
EBITDA Margin % | 14.53 | |||||
FCF Margin % | 6.58 | |||||
OCF Margin % | 13.24 | |||||
ROE % | 6.42 | |||||
ROA % | 2.49 | |||||
ROIC % | 5.04 | |||||
3-Year ROIIC % | 6.56 | |||||
ROC (Joel Greenblatt) % | 13.98 | |||||
ROCE % | 5.86 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 22.28 | |||||
Forward PE Ratio | 16.11 | |||||
PE Ratio without NRI | 15.98 | |||||
Shiller PE Ratio | 26.55 | |||||
Price-to-Owner-Earnings | 15.48 | |||||
PEG Ratio | 0.83 | |||||
PS Ratio | 0.99 | |||||
PB Ratio | 1.39 | |||||
Price-to-Free-Cash-Flow | 15.05 | |||||
Price-to-Operating-Cash-Flow | 7.48 | |||||
EV-to-EBIT | 16.68 | |||||
EV-to-Forward-EBIT | 11.32 | |||||
EV-to-EBITDA | 9.89 | |||||
EV-to-Forward-EBITDA | 8.34 | |||||
EV-to-Revenue | 1.44 | |||||
EV-to-Forward-Revenue | 1.68 | |||||
EV-to-FCF | 21.83 | |||||
Price-to-GF-Value | 0.9 | |||||
Price-to-Projected-FCF | 0.87 | |||||
Price-to-DCF (Earnings Based) | 0.61 | |||||
Price-to-DCF (FCF Based) | 0.95 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.98 | |||||
Earnings Yield (Greenblatt) % | 6 | |||||
FCF Yield % | 6.65 | |||||
Forward Rate of Return (Yacktman) % | 20.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Garofalo Health Care SpA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 489.256 | ||
| EPS (TTM) (€) | 0.246 | ||
| Beta | 0.015 | ||
| 3-Year Sharpe Ratio | -54.52 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 2.14 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 4.35 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 4.35 - 4.35 | ||
| Shares Outstanding (Mil) | 88.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Garofalo Health Care SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Garofalo Health Care SpA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.093000 Cash Dividend | 2026-05-18 | 4.35 (+0.00%) | ||
| EUR 0.086000 Cash Dividend | 2025-05-19 | 4.35 (+0.00%) |
Show
Entries
Garofalo Health Care SpA Frequently Asked Questions
What is Garofalo Health Care SpA(CHIX:GHCm)'s stock price today?
The current price of CHIX:GHCm is €4.35. The 52 week high of CHIX:GHCm is €4.35 and 52 week low is €4.35.
When is next earnings date of Garofalo Health Care SpA(CHIX:GHCm)?
The next earnings date of Garofalo Health Care SpA(CHIX:GHCm) is .
Does Garofalo Health Care SpA(CHIX:GHCm) pay dividends? If so, how much?
Garofalo Health Care SpA(CHIX:GHCm) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Garofalo Health Care SpA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers